<DOC>
	<DOCNO>NCT02792998</DOCNO>
	<brief_summary>The objective study : Stage 1 : To assess safety , tolerability , pharmacokinetic ( PK ) profile pharmacodynamic ( PD ) effect range dose IW-1701 tablet administer orally healthy subject 7 day repeat dose Stage 2 : To assess safety , tolerability , PK profile PD effect IW-1701 tablet administer orally healthy subject , feed fasted state , open-label , single-dose , 2-period , 2-sequence crossover study .</brief_summary>
	<brief_title>A Trial IW-1701 , A Stimulator Soluble Guanylate Cyclase ( sGC ) , Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Subject ambulatory male female 18 55 year old screening visit Subject 's body mass index score &gt; 18.5 &lt; 30.0 kg/m2 screen visit Women childbearing potential must negative pregnancy test time checkin must agree use doublebarrier contraception throughout duration study Subject good health clinically significant finding physical examination Other inclusion criterion per protocol History clinically significant medical condition Other exclusion criterion per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>